Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1993 Jan;67(1):112-4.
doi: 10.1038/bjc.1993.19.

A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands

A S Jones  1 , D E Phillips, J A Cook, T R Helliwell
Affiliations
Free PMC article
Clinical Trial

A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands

A S Jones et al. Br J Cancer. 1993 Jan.
Free PMC article

Abstract

Sixteen patients with advanced and recurrent malignant salivary gland tumours were admitted to a randomised trial and the response assessed. Seven patients received Epirubicin/5-Fluorouracil and none of these patients responded. Nine patients received Cisplatinum and only one patient had a partial response. The trial suggests that chemotherapy has no place in the treatment of advanced salivary gland malignant tumours.

PubMed Disclaimer

Comment in

References

    1. Cancer Chemother Rep. 1968 Oct;52(6):661-6 - PubMed
    1. Am J Surg. 1973 Oct;126(4):513-8 - PubMed
    1. Br J Cancer. 1977 Jan;35(1):1-39 - PubMed
    1. Cancer. 1977 Aug;40(2):619-24 - PubMed
    1. Cancer. 1979 May;43(5):1604-6 - PubMed